May 2023 FDA Recall Drug by New England Life Care, Inc. Dba Advanced Compounding Solutions
D-0778-2023 - Product Mix up; Product was compounded in 250 mL 5% Dextrose instead of 250 mL 0.9% Sodium Chloride

This Class III drug recall was voluntarily initiated by New England Life Care, Inc. Dba Advanced Compounding Solutions on May 22, 2023 for the product Drug. The FDA reported the reason for recall as product mix up; product was compounded in 250 ml 5% dextrose instead of 250 ml 0.9% sodium chloride. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0778-2023

Reason for Recall
Product Mix up; Product was compounded in 250 mL 5% Dextrose instead of 250 mL 0.9% Sodium Chloride
Initiated
05-22-2023
Reported
06-07-2023
Quantity
198

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
New England Life Care, Inc. dba Advanced Compounding Solutions
Nationwide in the USA.
Phenylephrine HCl 20 mg added to 0.9% Sodium Chloride 250mL Bag, Rx Only, Compounded by: Advanced Compounding Solutions, 4 Constitution Way Ste L Woburn, Massachusetts 01801-1042 United States, NDC 71546-451-25

Batch or Lot Expiration Information

Lot# 20230323-728BF8, exp. 08/20/2023